| Literature DB >> 31603636 |
Rosemary deShazo, Razieh Soltani-Arabshahi, Shalini Krishnasamy, Richard G. Langley, Sunil Kalia, Mona Ståhle, Wayne Langholff, Kavitha Goyal, Steve Fakharzadeh, Claudia Galindo, Bhaskar Srivastava, Gerald Krueger.
Abstract
To the Editor: Patients with psoriasis are at increased risk of developing non melanoma skin cancer (NMSC), including squamous cell carcinoma (SCC) and basal cell carcinoma (BCC).1,2 The risk is especially elevated among those who previously received systemic treatment or phototherapy.2 Systemic treatments, including biologic therapies and methotrexate (MTX), are effective in managing immune-mediated diseases; however, they may increase susceptibility to NMSC due to immunosuppression or other factors.3Entities:
Mesh：
Substances：
Year: 2019 PMID： 31603636
Source DB: PubMed Journal: J Drugs Dermatol ISSN： 1545-9616 Impact factor: 2.114